Assessment of the Alignment of the Atlas and Surrounding Tissues in Chronic Whiplash Associated Disorder
Condition(s) studied
Study summary
Whiplash is an injury caused by the rapid forward and backward movement of the neck, leading to injuries in bones or soft tissues, along with various symptoms. Recent studies indicate that muscles affected by whiplash may show increased fat buildup and reduced muscle volume. However, these changes in muscle do not completely account for the pain and other symptoms reported. Besides soft tissues, whiplash can also injure bone structures, including the cervical spine. Until now, studies focused mainly on fractures of the cervical spine, often overlooking the position and alignment of the atlas and dens (C1 and C2). The aim of this study is to evaluate the position and alignment of the Atlas in chronic whiplash-associated disorder (grades 1 or 2) and compare it to patients with tension headache and healthy controls. Additionally, it will explore how these factors relate to pain intensity, neck movement limitations, daily activities, overall improvement, and quality of life.
Eligibility
Primary outcome measure(s)
- Repeatability measurement — 12 months
MRI images will be used to measure the angles between the Atlas and adjacent vertebrae at two different time points in the same healthy participants. - Alignment of the Atlas — 12 months
MRI images will be used to measure the angles between the Atlas and adjacent vertebrae in the patient groups. - Neurological examination scores — 18 months
A neurological examination will be performed and scored during the participants' visit - Quality of life scores — 18 months
The scores will be obtained by using quality of life questionnaire
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Amsterdam UMC | Amsterdam | Netherlands | Recruiting |
More Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) trials in the Netherlands
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06413667 on ClinicalTrials.gov ↗ ← All trials in the Netherlands